About Us

About Us

Providing Our Clients with The Best Products

6

Company Information

HymonBio Co., Ltd. was established in 2015, with co-founders returning from the University of Texas and Chinese Academy of Sciences. The company focuses on the development, production, and sale of precision-medicine and point-of-care (POCT) related products. Since its establishment in Taicang Port, HymonBio has applied for 18 patents and obtained 6 authorized patents; 11 products have obtained Chinese medical device certificates; 2 products have obtained CE certificates; 1 product has obtained an FDA certificate and passed the ISO13485 system certificate. 

The company has won awards such as high-tech enterprises, private technology enterprises in Jiangsu Province, enterprises supported by the "Double Innovation Plan" of Jiangsu Province, and Suzhou Female Innovation and Entrepreneurship Leading Talent Enterprises. Most recently, HymonBio has completed the first round of financing, which is also the first overseas investment project of PerkinElmer Ventures, a leading company in the IVD industry, in China.

Our Focus

Relate to Precision Medicine and Point-of-Care Testing(POCT)

Our Model

Promote The Project Into The Market Through Cooperation, Rather Than Maximizing The Benefits Of A Single Product

Our Slogan

Use Limited Resources And Cooperation To Speed Up The Promotion Of New Products. 

Team Leaders

1-tammy

Tan Miao / Founder and CEO

> CEO of HymonBio. She received her doctorate from Shanghai Institute of physiology, Chinese Academy of Sciences in 2006 and was a visiting scholar of Max Planck Institute in Germany from 2005 to 2006.

> Once served as the R & D project manager of IVD listed company and was responsible for team management. Person in charge of national major special projects of the Ministry of science and technology. Member of the national health industry medical laboratory Expert Committee. Four SCI papers were published in international journals. 3 patented technologies. 2016 doctor of entrepreneurship and innovation in Jiangsu Province. Suzhou talents in 2017.

n1o4 (1)

Prof. Hua Tsen/CTO

> CTO of HymonBio. He received his doctorate in molecular and cell biology from the University of Texas at Dallas in 2000. Director of biological application transformation experimental center of Shenzhen Institute of advanced technology, Chinese Academy of Sciences, and professor of industry, medical school of Nantong University.

> Former director R & D Asia Pacific, Qiagen GmbH (Germany); Project leader of national 973 Plan and 863 plan; The Ministry of science and technology in 11th Five-Year and 12th Five-Year, the major sub project responsible person, "AIDS prevention and control special." Many SCI papers have been published in international journals, with 16 patented technologies.

1 (2)

Ma Xiaojuan/Project Director

> Project Director of HymonBio. She received her Master's degree in plant Physiology from Yangzhou University in 2005. Participated in the establishment of HymonBio company, focusing on the development and promotion of molecular diagnostics products.

> In the IVD industry has more than 10 years experience, a former r&d project managers of listed companies, has served as foreign enterprises quality control manager, assistant director of sales and marketing manager.

56

Sun Wentao/GM

> With more than 20 years of experience in IVD industry marketing and enterprise management, he has successively served as vice president of marketing, COO, and general manager of business divisions in many listed companies and leading companies in the IVD industry in China, including at Shanghai Kehua Bio-engineering Co.,Ltd. He has rich IVD industry resources, marketing management and operations management experience.